The results came out of a preliminary trial of 20 patients conducted by Olaf J. Bakker, MD, of University Medical Center Utrecht, the Netherlands, and colleagues.
They compared the proinflammatory response and clinical outcome of endoscopic transgastric and surgical necrosectomy. The trial was conducted in four hospitals in the Netherlands between August 2008 and March 2010.
Five of the 20 patients died (10 percent of patients in the endoscopy group vs. 40 percent of patients in the surgical necrosectomy group), with all deaths caused by persistent multiple organ failure, according to the researchers. Major complications were also reduced in patients in the endoscopy group (20 percent vs. 80 percent in the surgery group).
Related Articles on Endoscopy:
Cam Neely Foundation Gifts $1.5M to Tufts Medical for Endoscopy Suite Development, Renovation
ASGE Provides Tips for a Quality Colonoscopy
10 Recent Innovative Studies on Gastroenterology & Endoscopy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.